|
1
|
Sandberg AA and Bridge JA: Updates on the
cytogenetics and molecular genetics of bone and soft tissue tumors:
Osteosarcoma and related tumors. Cancer Genet Cytogenet. 145:1–30.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kansara M and Thomas DM: Molecular
pathogenesis of osteosarcoma. DNA Cell Biol. 26:1–18. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Savage SA, Mirabello L, Wang Z,
Gastier-Foster JM, Gorlick R, Khanna C, Flanagan AM, Tirabosco R,
Andrulis IL, Wunder JS, et al: Genome-wide association study
identifies two susceptibility loci for osteosarcoma. Nat Genet.
45:799–803. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mirabello L, Koster R, Moriarity BS,
Spector LG, Meltzer PS, Gary J, Machiela MJ, Pankratz N, Panagiotou
OA, Largaespada D, et al: A genome-wide scan identifies variants in
NFIB associated with metastasis in patients with osteosarcoma.
Cancer Discov. 5:920–931. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kovac M, Blattmann C, Ribi S, Smida J,
Mueller NS, Engert F, Castro-Giner F, Weischenfeldt J, Kovacova M,
Krieg A, et al: Exome sequencing of osteosarcoma reveals mutation
signatures reminiscent of BRCA deficiency. Nat Commun. 6:89402015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
dos Santos Aguiar S, de Jesus Girotto
Zambaldi L, dos Santos AM, Pinto W Jr and Brandalise SR:
Comparative genomic hybridization analysis of abnormalities in
chromosome 21 in childhood osteosarcoma. Cancer Genet Cytogenet.
175:35–40. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ohata N, Ito S, Yoshida A, Kunisada T,
Numoto K, Jitsumori Y, Kanzaki H, Ozaki T, Shimizu K and Ouchida M:
Highly frequent allelic loss of chromosome 6q16-23 in osteosarcoma:
Involvement of cyclin C in osteosarcoma. Int J Mol Med.
18:1153–1158. 2006.PubMed/NCBI
|
|
8
|
Atiye J, Wolf M, Kaur S, Monni O, Böhling
T, Kivioja A, Tas E, Serra M, Tarkkanen M and Knuutila S: Gene
amplifications in osteosarcoma-CGH microarray analysis. Genes
Chromosomes Cancer. 42:158–163. 2005. View Article : Google Scholar
|
|
9
|
Zielenska M, Marrano P, Thorner P, Pei J,
Beheshti B, Ho M, Bayani J, Liu Y, Sun BC, Squire JA, et al:
High-resolution cDNA microarray CGH mapping of genomic imbalances
in osteosarcoma using formalin-fixed paraffin-embedded tissue.
Cytogenet Genome Res. 107:77–82. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Man TK, Lu XY, Jaeweon K, Perlaky L,
Harris CP, Shah S, Ladanyi M, Gorlick R, Lau CC and Rao PH:
Genome-wide array comparative genomic hybridization analysis
reveals distinct amplifications in osteosarcoma. BMC Cancer.
4:452004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lau CC, Harris CP, Lu XY, Perlaky L,
Gogineni S, Chintagumpala M, Hicks J, Johnson ME, Davino NA, Huvos
AG, et al: Frequent amplification and rearrangement of chromosomal
bands 6p12-p21 and 17p11.2 in osteosarcoma. Genes Chromosomes
Cancer. 39:11–21. 2004. View Article : Google Scholar
|
|
12
|
Squire JA, Pei J, Marrano P, Beheshti B,
Bayani J, Lim G, Moldovan L and Zielenska M: High-resolution
mapping of amplifications and deletions in pediatric osteosarcoma
by use of CGH analysis of cDNA microarrays. Genes Chromosomes
Cancer. 38:215–225. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Overholtzer M, Rao PH, Favis R, Lu XY,
Elowitz MB, Barany F, Ladanyi M, Gorlick R and Levine AJ: The
presence of p53 mutations in human osteosarcomas correlates with
high levels of genomic instability. Proc Natl Acad Sci USA.
100:11547–11552. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yamamoto G, Nannya Y, Kato M, Sanada M,
Levine RL, Kawamata N, Hangaishi A, Kurokawa M, Chiba S, Gilliland
DG, et al: Highly sensitive method for genomewide detection of
allelic composition in nonpaired, primary tumor specimens by use of
affymetrix single-nucleotide-polymorphism genotyping microarrays.
Am J Hum Genet. 81:114–126. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lin DC, Meng X, Hazawa M, Nagata Y, Varela
AM, Xu L, Sato Y, Liu LZ, Ding LW, Sharma A, et al: The genomic
landscape of nasopharyngeal carcinoma. Nat Genet. 46:866–871. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lin DC, Xu L, Ding LW, Sharma A, Liu LZ,
Yang H, Tan P, Vadgama J, Karlan BY, Lester J, et al: Genomic and
functional characterizations of phosphodiesterase subtype 4D in
human cancers. Proc Natl Acad Sci USA. 110:6109–6114. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu Q, Huang J, Zhou N, Zhang Z, Zhang A,
Lu Z, Wu F and Mo YY: lncRNA loc285194 is a p53-regulated tumor
suppressor. Nucleic Acids Res. 41:4976–4987. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lin DC, Xu L, Chen Y, Yan H, Hazawa M,
Doan N, Said JW, Ding LW, Liu LZ, Yang H, et al: Genomic and
functional analysis of the E3 ligase PARK2 in glioma. Cancer Res.
75:1815–1827. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jiang YY, Lin DC, Mayakonda A, Hazawa M,
Ding LW, Chien WW, Xu L, Chen Y, Xiao JF, Senapedis W, et al:
Targeting super-enhancer-associated oncogenes in oesophageal
squamous cell carcinoma. Gut. May 10–2016.Epub ahead of print.
2016.PubMed/NCBI
|
|
20
|
Pasic I, Shlien A, Durbin AD, Stavropoulos
DJ, Baskin B, Ray PN, Novokmet A and Malkin D: Recurrent focal
copy-number changes and loss of heterozygosity implicate two
noncoding RNAs and one tumor suppressor gene at chromosome 3q13.31
in osteosarcoma. Cancer Res. 70:160–171. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lin WM, Baker AC, Beroukhim R, Winckler W,
Feng W, Marmion JM, Laine E, Greulich H, Tseng H, Gates C, et al:
Modeling genomic diversity and tumor dependency in malignant
melanoma. Cancer Res. 68:664–673. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Calhoun ES, Hucl T, Gallmeier E, West KM,
Arking DE, Maitra A, Iacobuzio-Donahue CA, Chakravarti A, Hruban RH
and Kern SE: Identifying allelic loss and homozygous deletions in
pancreatic cancer without matched normals using high-density
single-nucleotide polymorphism arrays. Cancer Res. 66:7920–7928.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nancarrow DJ, Handoko HY, Smithers BM,
Gotley DC, Drew PA, Watson DI, Clouston AD, Hayward NK and Whiteman
DC: Genome-wide copy number analysis in esophageal adenocarcinoma
using high-density single-nucleotide polymorphism arrays. Cancer
Res. 68:4163–4172. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Teh MT, Blaydon D, Chaplin T, Foot NJ,
Skoulakis S, Raghavan M, Harwood CA, Proby CM, Philpott MP, Young
BD, et al: Genomewide single nucleotide polymorphism microarray
mapping in basal cell carcinomas unveils uniparental disomy as a
key somatic event. Cancer Res. 65:8597–8603. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xue YL, Meng XQ, Ma LJ and Yuan Z:
Plumbagin exhibits an anti-proliferative effect in human
osteosarcoma cells by downregulating FHL2 and interfering with
Wnt/β-catenin signalling. Oncol Lett. 12:1095–1100. 2016.PubMed/NCBI
|
|
26
|
Lv YF, Dai H, Yan GN, Meng G, Zhang X and
Guo QN: Downregulation of tumor suppressing STF cDNA 3 promotes
epithelial-mesenchymal transition and tumor metastasis of
osteosarcoma by the Wnt/GSK-3β/β-catenin/Snail signaling pathway.
Cancer Lett. 373:164–173. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ng TL, Gown AM, Barry TS, Cheang MC, Chan
AK, Turbin DA, Hsu FD, West RB and Nielsen TO: Nuclear beta-catenin
in mesenchymal tumors. Mod Pathol. 18:68–74. 2005. View Article : Google Scholar
|
|
28
|
Yen CC, Chen WM, Chen TH, Chen WY, Chen
PC, Chiou HJ, Hung GY, Wu HT, Wei CJ, Shiau CY, et al:
Identification of chromosomal aberrations associated with disease
progression and a novel 3q13.31 deletion involving LSAMP gene in
osteosarcoma. Int J Oncol. 35:775–788. 2009.PubMed/NCBI
|
|
29
|
Kresse SH, Ohnstad HO, Paulsen EB,
Bjerkehagen B, Szuhai K, Serra M, Schaefer KL, Myklebost O and
Meza-Zepeda LA: LSAMP, a novel candidate tumor suppressor gene in
human osteosarcomas, identified by array comparative genomic
hybridization. Genes Chromosomes Cancer. 48:679–693. 2009.
View Article : Google Scholar : PubMed/NCBI
|
